AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias.
Sykes SM, Lane SW, Bullinger L, Kalaitzidis D, Yusuf R, Saez B, Ferraro F, Mercier F, Singh H, Brumme KM, Acharya SS, Scholl C, Tothova Z, Attar EC, Fröhling S, DePinho RA, Armstrong SA, Gilliland DG, Scadden DT.
Sykes SM, et al. Among authors: acharya ss.
Cell. 2011 Sep 2;146(5):697-708. doi: 10.1016/j.cell.2011.07.032.
Cell. 2011.
PMID: 21884932
Free PMC article.